CCNE1 and hepatocellular carcinoma: Further, suppression of NF90 delays cell cycle progress and cell growth in human hepatocellular carcinoma (HCC) cell lines through binding to the 3′-UTR of Cyclin E1 mRNA, and reduces the sensitivity of HCC cells to the roscovitine, a CDK inhibitor that is applied in II experiments18.